Melisron CEO dies at 54: what it means for Melisron stock

Published on 10/20/2026 at 09:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Oren Hilinger became acting CEO after Ophir Sarid died at 54. Melisron stock now carries a leadership transition into its November 25 results.

Leadership transition and results

Ophir Sarid died at age 54 on September 28, 2026.
Second-quarter net income reached ILS 289.0 million for the period ended June 30, 2026.
Melisron's market capitalization was ILS 19.2 billion as of October 16, 2026.

Melisron, IL0003230146, Illustration mit AI erstellt.

Melisron CEO Ophir Sarid died at age 54 on September 28, 2026, after a severe illness, while Oren Hilinger took over as acting chief executive. The leadership change gives Melisron stock a fresh governance focus ahead of the company's next scheduled results.

Three events changed the picture

The latest twelve-month chronology starts with August 13, 2026, when Melisron reported second-quarter net income of ILS 289.0 million and net operating income of ILS 412.0 million in its investor-relations materials at Melisron. On September 2, 2026, the company announced that Sarid was taking medical leave, according to CTech. On September 28, 2026, CTech reported Sarid's death at 54 and said Hilinger had become acting CEO pending a permanent successor.

What does the transition mean?

The financial base entering the transition was substantial. Melisron's second-quarter revenue was ILS 588.0 million, net income was ILS 289.0 million, and operating cash flow was ILS 282.0 million for the period ended June 30, 2026. Net income therefore stood ILS 24.0 million above the ILS 265.0 million reported for the preceding quarter, a 9.06 percent increase.

The company said its portfolio comprised 29 owned rental properties with an average occupancy rate of 97.8 percent as of June 30, 2026. Its investor-relations page also lists annual mall sales of ILS 10.5 billion and total asset value of ILS 28.0 billion, framing the leadership issue against a large operating platform.

When are the next dates?

Melisron's next earnings report is scheduled for November 25, 2026, according to TradingView. The date matters because management continuity will be assessed alongside the next quarterly figures.

Market value frames the change

Melisron's investor-relations page showed a market capitalization of ILS 19.2 billion as of October 16, 2026. The company is listed on the Tel Aviv Stock Exchange and belongs to the TA-35 and Tel Aviv 125 indexes, so the acting-CEO period affects a widely followed Israeli real-estate name.

The further course of trading is shown by the real-time quote of Melisron stock.